|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2003-6-9
|
|
pubmed:abstractText |
Langerhans cell histiocytosis (LCH) is a rare disease with variable prognosis in which lesions and clinical features suggest that pro- and anti-inflammatory cytokines may be involved in its pathogenesis. The authors wished to evaluate whether serum levels of interleukin-1 receptor agonist (IL-1Ra) and tumor necrosis factor-alpha (TNF-alpha) are elevated in children with LCH and decrease after chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/IL1RN protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin 1 Receptor Antagonist...,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Sialoglycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1077-4114
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
480-3
|
|
pubmed:dateRevised |
2011-10-6
|
|
pubmed:meshHeading |
pubmed-meshheading:12794527-Adolescent,
pubmed-meshheading:12794527-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12794527-Child,
pubmed-meshheading:12794527-Child, Preschool,
pubmed-meshheading:12794527-Etoposide,
pubmed-meshheading:12794527-Female,
pubmed-meshheading:12794527-Histiocytosis, Langerhans-Cell,
pubmed-meshheading:12794527-Humans,
pubmed-meshheading:12794527-Infant,
pubmed-meshheading:12794527-Interleukin 1 Receptor Antagonist Protein,
pubmed-meshheading:12794527-Male,
pubmed-meshheading:12794527-Predictive Value of Tests,
pubmed-meshheading:12794527-Prednisolone,
pubmed-meshheading:12794527-Receptors, Interleukin-1,
pubmed-meshheading:12794527-Recombinant Proteins,
pubmed-meshheading:12794527-Sialoglycoproteins,
pubmed-meshheading:12794527-Tumor Necrosis Factor-alpha,
pubmed-meshheading:12794527-Vinblastine
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Serum levels of interleukin-1 receptor antagonist and tumor necrosis factor-alpha are elevated in children with Langerhans cell histiocytosis.
|
|
pubmed:affiliation |
Department of Hematology-Oncology, Hospital de Pediatría Dr. JP Garrahan, Buenos Aires, Argentina. drosso_2000@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
